tetradecanoylphorbol acetate has been researched along with lucidenic acid n in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chau, CF; Chen, DH; Chen, KD; Weng, CJ; Yen, GC | 1 |
| Chau, CF; Hsieh, YS; Weng, CJ; Yang, SF; Yen, GC | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and lucidenic acid n
| Article | Year |
|---|---|
The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cholic Acids; Chromatography, High Pressure Liquid; Ganoderma; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Terpenes; Tetradecanoylphorbol Acetate; Triterpenes | 2007 |
Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; MAP Kinase Signaling System; Neoplasm Invasiveness; NF-kappa B; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Triterpenes | 2008 |